Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000030481Phase 4Recruiting
Phase 4, randomised, open-label trial of corticosteroids in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Time to negative SARS-CoV-2 RT-PCR. Started Mar 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000030481.